Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA May Ask Congress For More Resources After Withdrawing Generic Label Reg

Dec 14 2018

• By Michael Cipriano

BMS R&D — Definitely looks like it needs an update

Related Content

US FDA's Label Updating Effort Needs Legislation To Impact Generics

Mar 21 2018

Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing

Feb 21 2015

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

Generic Labeling Rule Dies In Latest Reg Agenda, But Electronic Labeling Is Reborn

Dec 15 2017

US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot

Jan 29 2018

FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield

Nov 09 2013

Project Renewal: US FDA's Plan To Update Generic Cancer Drug Labels Depends On NDA Holders

Nov 28 2018

Additional Topics

United States Generic Drugs FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window